| Sources | Names Used |
|---|---|
| CTRPv2 | Repligen 136 |
| PharmacoGx | Repligen 136 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CT45A9 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | UGP2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CGREF1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ALG8 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | PTTG1IP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PTPN21 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | COL25A1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ZNF362 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | KIR2DL3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ZFP1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
